Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Astrocytoma 8Glioblastoma 5Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Recurrence 3Prostatic Neoplasms 3Lung Neoplasms 3Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neurofibroma 1Neuroblastoma 1

Interventions

Cyclophosphamide 9Temozolomide 7Radiotherapy 6Magnetic Resonance Spectroscopy 5Filgrastim 5Cisplatin 5Carboplatin 5antineoplaston AS 2-1 4antineoplaston A10 4Etoposide 4sargramostim 3Vincristine 3Thiotepa 3Melphalan 3Automobiles 3fludarabine 2aldesleukin 2Thalidomide 2Surveys and Questionnaires 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Gadolinium DTPA 2Eflornithine 2Donepezil 2Carmustine 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trifluridine tipiracil drug combination 1trametinib 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive × antineoplaston AS 2-1 × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003515 2017-09-29

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Burzynski Research Institute

Phase 2 Terminated
1 enrolled

Neuroectodermal Tumors, Primitive

NCT00003460 2017-08-24

PNET

Burzynski Research Institute

Phase 2 Completed
13 enrolled 6 charts

Neuroectodermal Tumors, Primitive

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡